Macrocyclic hepatitis C serine protease inhibitors

The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, o...

Full description

Saved in:
Bibliographic Details
Main Authors SHANLEY JASON P, LIU DONG, SHEIKH AHMAD, GAI YONGHUA, SUN YING, GRIEME TIM, GRAMPOVNIK DAVID J, KU YIYIN, OR YAT SUN, ENGSTROM KEN, MCDANIEL KEITH F, WAGAW SEBLE H, MEI JIANZHANG, KEMPF DALE J, CHEN HUI-JU
Format Patent
LanguageEnglish
Published 10.06.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel macrocyclic compounds and methods of treating a hepatitis C infection in a subject in need of such therapy with said macrocyclic compounds. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
Bibliography:Application Number: US20090584716